Medication Safety Principles and Practice in CKD

Ensuring patient safety is a priority of medical care because iatrogenic injury has been a primary concern. Medications are an important source of medical errors, and kidney disease is a thoroughfare of factors threatening safe administration of medicines. Principal among these is reduced kidney fun...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical journal of the American Society of Nephrology 2018-11, Vol.13 (11), p.1738-1746
Hauptverfasser: Whittaker, Chanel F, Miklich, Margaret A, Patel, Roshni S, Fink, Jeffrey C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1746
container_issue 11
container_start_page 1738
container_title Clinical journal of the American Society of Nephrology
container_volume 13
creator Whittaker, Chanel F
Miklich, Margaret A
Patel, Roshni S
Fink, Jeffrey C
description Ensuring patient safety is a priority of medical care because iatrogenic injury has been a primary concern. Medications are an important source of medical errors, and kidney disease is a thoroughfare of factors threatening safe administration of medicines. Principal among these is reduced kidney function because almost half of all medications used are eliminated the kidney. Additionally, kidney patients often suffer from multimorbidity, including diabetes, hypertension, and heart failure, with a range of prescribers who often do not coordinate treatments. Patients with kidney disease are also susceptible to further kidney injury and metabolic derangements from medications, which can worsen the disease. In this review, we will present the key issues and threats to safe medication use in kidney disease, with a focus on predialysis CKD, as the scope of medication safety in ESKD and transplantation are unique and deserve their own consideration. We discuss drugs that need to be avoided or dose modified, and review the complications of a range of medications routinely administered in CKD, as these also call for cautious use.
doi_str_mv 10.2215/CJN.00580118
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6237057</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2057122621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-79c2c678369fded55ebdc3430d2541dcaa4f9f8b3abf583a3c3b7be705933c213</originalsourceid><addsrcrecordid>eNpVkMtLxDAQh4Mo7rp68yw9erBrnm1zEaS-XR-ggreQ5qGRblqTrrD_vdV9oKeZYT6-GX4A7CM4xhix4_LmfgwhKyBCxQYYIsZYyiF73Vz3FA3ATowfEFJKMNsGA8w5YoigIYB3RjslO9f45Ela082Tx-C8cm1tYiK97kepOqdM4nxS3p7tgi0r62j2lnUEXi7On8urdPJweV2eTlJFcd6lOVdYZXlBMm610YyZSitCCdSYUaSVlNRyW1REVpYVRBJFqrwyOWScEIURGYGThbedVVOjlfFdkLVog5vKMBeNdOL_xrt38dZ8iQyT3pL3gsOlIDSfMxM7MXVRmbqW3jSzKHAPIYyz31tHC1SFJsZg7PoMguInZNGHLFYh9_jB39fW8CpV8g0dGXb8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2057122621</pqid></control><display><type>article</type><title>Medication Safety Principles and Practice in CKD</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Whittaker, Chanel F ; Miklich, Margaret A ; Patel, Roshni S ; Fink, Jeffrey C</creator><creatorcontrib>Whittaker, Chanel F ; Miklich, Margaret A ; Patel, Roshni S ; Fink, Jeffrey C</creatorcontrib><description>Ensuring patient safety is a priority of medical care because iatrogenic injury has been a primary concern. Medications are an important source of medical errors, and kidney disease is a thoroughfare of factors threatening safe administration of medicines. Principal among these is reduced kidney function because almost half of all medications used are eliminated the kidney. Additionally, kidney patients often suffer from multimorbidity, including diabetes, hypertension, and heart failure, with a range of prescribers who often do not coordinate treatments. Patients with kidney disease are also susceptible to further kidney injury and metabolic derangements from medications, which can worsen the disease. In this review, we will present the key issues and threats to safe medication use in kidney disease, with a focus on predialysis CKD, as the scope of medication safety in ESKD and transplantation are unique and deserve their own consideration. We discuss drugs that need to be avoided or dose modified, and review the complications of a range of medications routinely administered in CKD, as these also call for cautious use.</description><identifier>ISSN: 1555-9041</identifier><identifier>ISSN: 1555-905X</identifier><identifier>EISSN: 1555-905X</identifier><identifier>DOI: 10.2215/CJN.00580118</identifier><identifier>PMID: 29915131</identifier><language>eng</language><publisher>United States: American Society of Nephrology</publisher><subject>Acute Kidney Injury - chemically induced ; Anemia - drug therapy ; Anemia - etiology ; Anemia - therapy ; Angiotensin Receptor Antagonists - adverse effects ; Angiotensin-Converting Enzyme Inhibitors - adverse effects ; Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy ; Chronic Kidney Disease-Mineral and Bone Disorder - etiology ; Diuretics - adverse effects ; Humans ; Hyperkalemia - drug therapy ; Hyperkalemia - etiology ; Hypoglycemic Agents - adverse effects ; Hypokalemia - drug therapy ; Hypokalemia - etiology ; Kidney Failure, Chronic - physiopathology ; Kidney Transplantation ; Medication Reconciliation ; Nephropharmacology for the Clinician ; Patient Safety ; Renal Insufficiency, Chronic - complications ; Renal Insufficiency, Chronic - physiopathology</subject><ispartof>Clinical journal of the American Society of Nephrology, 2018-11, Vol.13 (11), p.1738-1746</ispartof><rights>Copyright © 2018 by the American Society of Nephrology.</rights><rights>Copyright © 2018 by the American Society of Nephrology 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-79c2c678369fded55ebdc3430d2541dcaa4f9f8b3abf583a3c3b7be705933c213</citedby><cites>FETCH-LOGICAL-c427t-79c2c678369fded55ebdc3430d2541dcaa4f9f8b3abf583a3c3b7be705933c213</cites><orcidid>0000-0001-7877-897 ; 0000-0002-1075-7459</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237057/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237057/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29915131$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Whittaker, Chanel F</creatorcontrib><creatorcontrib>Miklich, Margaret A</creatorcontrib><creatorcontrib>Patel, Roshni S</creatorcontrib><creatorcontrib>Fink, Jeffrey C</creatorcontrib><title>Medication Safety Principles and Practice in CKD</title><title>Clinical journal of the American Society of Nephrology</title><addtitle>Clin J Am Soc Nephrol</addtitle><description>Ensuring patient safety is a priority of medical care because iatrogenic injury has been a primary concern. Medications are an important source of medical errors, and kidney disease is a thoroughfare of factors threatening safe administration of medicines. Principal among these is reduced kidney function because almost half of all medications used are eliminated the kidney. Additionally, kidney patients often suffer from multimorbidity, including diabetes, hypertension, and heart failure, with a range of prescribers who often do not coordinate treatments. Patients with kidney disease are also susceptible to further kidney injury and metabolic derangements from medications, which can worsen the disease. In this review, we will present the key issues and threats to safe medication use in kidney disease, with a focus on predialysis CKD, as the scope of medication safety in ESKD and transplantation are unique and deserve their own consideration. We discuss drugs that need to be avoided or dose modified, and review the complications of a range of medications routinely administered in CKD, as these also call for cautious use.</description><subject>Acute Kidney Injury - chemically induced</subject><subject>Anemia - drug therapy</subject><subject>Anemia - etiology</subject><subject>Anemia - therapy</subject><subject>Angiotensin Receptor Antagonists - adverse effects</subject><subject>Angiotensin-Converting Enzyme Inhibitors - adverse effects</subject><subject>Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy</subject><subject>Chronic Kidney Disease-Mineral and Bone Disorder - etiology</subject><subject>Diuretics - adverse effects</subject><subject>Humans</subject><subject>Hyperkalemia - drug therapy</subject><subject>Hyperkalemia - etiology</subject><subject>Hypoglycemic Agents - adverse effects</subject><subject>Hypokalemia - drug therapy</subject><subject>Hypokalemia - etiology</subject><subject>Kidney Failure, Chronic - physiopathology</subject><subject>Kidney Transplantation</subject><subject>Medication Reconciliation</subject><subject>Nephropharmacology for the Clinician</subject><subject>Patient Safety</subject><subject>Renal Insufficiency, Chronic - complications</subject><subject>Renal Insufficiency, Chronic - physiopathology</subject><issn>1555-9041</issn><issn>1555-905X</issn><issn>1555-905X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkMtLxDAQh4Mo7rp68yw9erBrnm1zEaS-XR-ggreQ5qGRblqTrrD_vdV9oKeZYT6-GX4A7CM4xhix4_LmfgwhKyBCxQYYIsZYyiF73Vz3FA3ATowfEFJKMNsGA8w5YoigIYB3RjslO9f45Ela082Tx-C8cm1tYiK97kepOqdM4nxS3p7tgi0r62j2lnUEXi7On8urdPJweV2eTlJFcd6lOVdYZXlBMm610YyZSitCCdSYUaSVlNRyW1REVpYVRBJFqrwyOWScEIURGYGThbedVVOjlfFdkLVog5vKMBeNdOL_xrt38dZ8iQyT3pL3gsOlIDSfMxM7MXVRmbqW3jSzKHAPIYyz31tHC1SFJsZg7PoMguInZNGHLFYh9_jB39fW8CpV8g0dGXb8</recordid><startdate>20181107</startdate><enddate>20181107</enddate><creator>Whittaker, Chanel F</creator><creator>Miklich, Margaret A</creator><creator>Patel, Roshni S</creator><creator>Fink, Jeffrey C</creator><general>American Society of Nephrology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7877-897</orcidid><orcidid>https://orcid.org/0000-0002-1075-7459</orcidid></search><sort><creationdate>20181107</creationdate><title>Medication Safety Principles and Practice in CKD</title><author>Whittaker, Chanel F ; Miklich, Margaret A ; Patel, Roshni S ; Fink, Jeffrey C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-79c2c678369fded55ebdc3430d2541dcaa4f9f8b3abf583a3c3b7be705933c213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acute Kidney Injury - chemically induced</topic><topic>Anemia - drug therapy</topic><topic>Anemia - etiology</topic><topic>Anemia - therapy</topic><topic>Angiotensin Receptor Antagonists - adverse effects</topic><topic>Angiotensin-Converting Enzyme Inhibitors - adverse effects</topic><topic>Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy</topic><topic>Chronic Kidney Disease-Mineral and Bone Disorder - etiology</topic><topic>Diuretics - adverse effects</topic><topic>Humans</topic><topic>Hyperkalemia - drug therapy</topic><topic>Hyperkalemia - etiology</topic><topic>Hypoglycemic Agents - adverse effects</topic><topic>Hypokalemia - drug therapy</topic><topic>Hypokalemia - etiology</topic><topic>Kidney Failure, Chronic - physiopathology</topic><topic>Kidney Transplantation</topic><topic>Medication Reconciliation</topic><topic>Nephropharmacology for the Clinician</topic><topic>Patient Safety</topic><topic>Renal Insufficiency, Chronic - complications</topic><topic>Renal Insufficiency, Chronic - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Whittaker, Chanel F</creatorcontrib><creatorcontrib>Miklich, Margaret A</creatorcontrib><creatorcontrib>Patel, Roshni S</creatorcontrib><creatorcontrib>Fink, Jeffrey C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Whittaker, Chanel F</au><au>Miklich, Margaret A</au><au>Patel, Roshni S</au><au>Fink, Jeffrey C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medication Safety Principles and Practice in CKD</atitle><jtitle>Clinical journal of the American Society of Nephrology</jtitle><addtitle>Clin J Am Soc Nephrol</addtitle><date>2018-11-07</date><risdate>2018</risdate><volume>13</volume><issue>11</issue><spage>1738</spage><epage>1746</epage><pages>1738-1746</pages><issn>1555-9041</issn><issn>1555-905X</issn><eissn>1555-905X</eissn><abstract>Ensuring patient safety is a priority of medical care because iatrogenic injury has been a primary concern. Medications are an important source of medical errors, and kidney disease is a thoroughfare of factors threatening safe administration of medicines. Principal among these is reduced kidney function because almost half of all medications used are eliminated the kidney. Additionally, kidney patients often suffer from multimorbidity, including diabetes, hypertension, and heart failure, with a range of prescribers who often do not coordinate treatments. Patients with kidney disease are also susceptible to further kidney injury and metabolic derangements from medications, which can worsen the disease. In this review, we will present the key issues and threats to safe medication use in kidney disease, with a focus on predialysis CKD, as the scope of medication safety in ESKD and transplantation are unique and deserve their own consideration. We discuss drugs that need to be avoided or dose modified, and review the complications of a range of medications routinely administered in CKD, as these also call for cautious use.</abstract><cop>United States</cop><pub>American Society of Nephrology</pub><pmid>29915131</pmid><doi>10.2215/CJN.00580118</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-7877-897</orcidid><orcidid>https://orcid.org/0000-0002-1075-7459</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1555-9041
ispartof Clinical journal of the American Society of Nephrology, 2018-11, Vol.13 (11), p.1738-1746
issn 1555-9041
1555-905X
1555-905X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6237057
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Acute Kidney Injury - chemically induced
Anemia - drug therapy
Anemia - etiology
Anemia - therapy
Angiotensin Receptor Antagonists - adverse effects
Angiotensin-Converting Enzyme Inhibitors - adverse effects
Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy
Chronic Kidney Disease-Mineral and Bone Disorder - etiology
Diuretics - adverse effects
Humans
Hyperkalemia - drug therapy
Hyperkalemia - etiology
Hypoglycemic Agents - adverse effects
Hypokalemia - drug therapy
Hypokalemia - etiology
Kidney Failure, Chronic - physiopathology
Kidney Transplantation
Medication Reconciliation
Nephropharmacology for the Clinician
Patient Safety
Renal Insufficiency, Chronic - complications
Renal Insufficiency, Chronic - physiopathology
title Medication Safety Principles and Practice in CKD
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T21%3A49%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medication%20Safety%20Principles%20and%20Practice%20in%20CKD&rft.jtitle=Clinical%20journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=Whittaker,%20Chanel%20F&rft.date=2018-11-07&rft.volume=13&rft.issue=11&rft.spage=1738&rft.epage=1746&rft.pages=1738-1746&rft.issn=1555-9041&rft.eissn=1555-905X&rft_id=info:doi/10.2215/CJN.00580118&rft_dat=%3Cproquest_pubme%3E2057122621%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2057122621&rft_id=info:pmid/29915131&rfr_iscdi=true